Lugtenburg, P., Avivi, I., Berenschot, H., Ilhan, O., Marolleau, J. P., Nagler, A., Rueda, A., Tani, M., Turgut, M., Osborne, S., Smith, R. and Pfreundschuh, M. (2017) “Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study”, Haematologica. Pavia, Italy, 102(11), pp. 1913-1922. doi: 10.3324/haematol.2017.173583.